Meningococcal Vaccines Market to hit USD 7.8 Bn by 2032, says Global Market Insights Inc.
GlobeNewswire
Meningococcal Vaccines industry is projected to witness a CAGR of 6.5% during the period 2024-2032. This growth can be due to..
Meningococcal Vaccines industry is projected to witness a CAGR of 6.5% during the period 2024-2032. This growth can be due to..
SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,..
· *New strategic partnership will scale-up manufacturing capacity to support global supply of dengue vaccine and expands Takeda's..